labetalol has been researched along with Clostridium tetani Infection in 9 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Wide variation in dosage was needed both from case to case and in the same patient during the course of his disease." | 5.27 | Labetalol in tetanus. The treatment of sympathetic nervous system overactivity. ( Hariparsad, D; Pather, M; Rocke, DA; Wesley, AG, 1983) |
| " It has also been used intravenously in phaeochromocytoma, tetanus, clonidine withdrawal, and as an adjunct to halothane to produce hypotensive anaesthesia." | 4.76 | Combined alpha- and beta-receptor inhibition in the treatment of hypertension. ( Prichard, BN, 1984) |
| " Wide variation in dosage was needed both from case to case and in the same patient during the course of his disease." | 1.27 | Labetalol in tetanus. The treatment of sympathetic nervous system overactivity. ( Hariparsad, D; Pather, M; Rocke, DA; Wesley, AG, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanna, W | 1 |
| Grell, GA | 1 |
| Prichard, BN | 1 |
| Domenighetti, GM | 2 |
| Savary, G | 2 |
| Stricker, H | 1 |
| Wesley, AG | 2 |
| Hariparsad, D | 1 |
| Pather, M | 2 |
| Rocke, DA | 1 |
| Dundee, JW | 1 |
| Morrow, WF | 1 |
| Omar, MA | 1 |
| Connor, H | 1 |
| Hine, IP | 1 |
| Hart, DG | 1 |
1 review available for labetalol and Clostridium tetani Infection
| Article | Year |
|---|---|
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia; Antihyp | 1984 |
8 other studies available for labetalol and Clostridium tetani Infection
| Article | Year |
|---|---|
Oral labetalol in the management of the sympathetic overactivity of severe tetanus.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Blood Pressu | 1980 |
Hyperadrenergic syndrome in severe tetanus: extreme rise in catecholamines responsive to labetalol.
Topics: Adrenergic Fibers; Aged; Catecholamines; Ethanolamines; Humans; Hypertension; Labetalol; Male; Nervo | 1984 |
Tetanus: sympathetic overactivity.
Topics: Aged; Hemodynamics; Humans; Hypertension; Labetalol; Male; Sympathetic Nervous System; Tetanus | 1984 |
Labetalol in tetanus. The treatment of sympathetic nervous system overactivity.
Topics: Adolescent; Adult; Blood Pressure; Cardiac Output; Child; Child, Preschool; Ethanolamines; Female; H | 1983 |
Labetalol in severe tetanus.
Topics: Adult; Atropine; Ethanolamines; Humans; Infusions, Parenteral; Labetalol; Male; Tetanus | 1979 |
Labetalol in severe tetanus.
Topics: Adult; Ethanolamines; Humans; Labetalol; Tetanus | 1979 |
Labetalol in severe tetanus.
Topics: Aged; Arrhythmias, Cardiac; Ethanolamines; Female; Humans; Infusions, Parenteral; Labetalol; Tetanus | 1979 |
Labetalol in hypertensive emergencies.
Topics: Adolescent; Emergencies; Ethanolamines; Humans; Hypertension; Labetalol; Male; Tetanus | 1978 |